Explainable machine learning for predicting grade ≥3 treatment-related adverse events in resectable non-small cell lung cancer receiving neoadjuvant chemoimmunotherapy: predominant contribution of hematologic toxicity

Fei-Hang Zhi, Yunzeng Zhang, Tengfei Ge, Lei Yang, Yichen Dong, Jialiang Wen, Haojie Si, Jingyu Chen, Yuzhou Wang, Delun Yang, Yicheng Wang, Minglei Yang, Huikang Xie, Junqi Wu, Long Xu, Deping Zhao, Chang Chen

Open source

DOI
10.21037/tlcr-2026-0984
Published
2026-10
Container
Translational Lung Cancer Research
Publisher
AME Publishing Company
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.21037/tlcr-2026-0984,
  title = {Explainable machine learning for predicting grade ≥3 treatment-related adverse events in resectable non-small cell lung cancer receiving neoadjuvant chemoimmunotherapy: predominant contribution of hematologic toxicity},
  author = {Fei-Hang Zhi and Yunzeng Zhang and Tengfei Ge and Lei Yang and Yichen Dong and Jialiang Wen and Haojie Si and Jingyu Chen and Yuzhou Wang and Delun Yang and Yicheng Wang and Minglei Yang and Huikang Xie and Junqi Wu and Long Xu and Deping Zhao and Chang Chen},
  year = {2026},
  journal = {Translational Lung Cancer Research},
  doi = {10.21037/tlcr-2026-0984},
  url = {https://doi.org/10.21037/tlcr-2026-0984}
}

RIS

TY  - JOUR
TI  - Explainable machine learning for predicting grade ≥3 treatment-related adverse events in resectable non-small cell lung cancer receiving neoadjuvant chemoimmunotherapy: predominant contribution of hematologic toxicity
AU  - Fei-Hang Zhi
AU  - Yunzeng Zhang
AU  - Tengfei Ge
AU  - Lei Yang
AU  - Yichen Dong
AU  - Jialiang Wen
AU  - Haojie Si
AU  - Jingyu Chen
AU  - Yuzhou Wang
AU  - Delun Yang
AU  - Yicheng Wang
AU  - Minglei Yang
AU  - Huikang Xie
AU  - Junqi Wu
AU  - Long Xu
AU  - Deping Zhao
AU  - Chang Chen
PY  - 2026
JO  - Translational Lung Cancer Research
DO  - 10.21037/tlcr-2026-0984
UR  - https://doi.org/10.21037/tlcr-2026-0984
ER  - 

APA

Zhi, F., Zhang, Y., Ge, T., Yang, L., Dong, Y., Wen, J., Si, H., Chen, J., Wang, Y., Yang, D., Wang, Y., Yang, M., Xie, H., Wu, J., Xu, L., Zhao, D., & Chen, C. (2026). Explainable machine learning for predicting grade ≥3 treatment-related adverse events in resectable non-small cell lung cancer receiving neoadjuvant chemoimmunotherapy: predominant contribution of hematologic toxicity. Translational Lung Cancer Research. https://doi.org/10.21037/tlcr-2026-0984

Source records